ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,167.60
0.00%
Dow Jones
38,589.16
-0.15%
Brent Oil
82.235
0.13%
Bitcoin
66,238.18
-0.60%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. InflaRx NV (IFRX) Quote

InflaRx NV

InflaRx NV (IFRX)

NASDAQ
1.56
0.00
(0.00%)
Closed June 17 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.56
Bid
1.48
Ask
1.70
Volume
-
0.00 Day's Range 0.00
1.14 52 Week Range 4.70
Market Cap
84.42M
Previous Close
1.56
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
199,667
Shares Outstanding
54,115,530
Dividend Yield
-
PE Ratio
-1.98
Earnings Per Share (EPS)
-0.79
Revenue
63k
Net Profit
-42.67M

About InflaRx NV

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator in... InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.inflarx.de
Headquarters
Jena, Deu
Founded
1970
InflaRx NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IFRX. The last closing price for InflaRx NV was $1.56. Over the last year, InflaRx NV shares have traded in a share price range of $ 1.14 to $ 4.70.

InflaRx NV currently has 54,115,530 shares outstanding. The market capitalization of InflaRx NV is $84.42 million. InflaRx NV has a price to earnings ratio (PE ratio) of -1.98.

IFRX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

June 05 2024
Edgar (US Regulatory)

InflaRx Hosts R&D Event Highlighting the Promise of INF904

Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential...

June 05 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 21 2024
Edgar (US Regulatory)

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced...

May 21 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 08 2024
Edgar (US Regulatory)

InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update

Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the opportunity, the role of C5aR in chronic spontaneous urticaria (CSU) and...

May 08 2024
GlobeNewswire Inc.

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

JENA, Germany, April 30, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

April 30 2024
GlobeNewswire Inc.

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event

JENA, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

April 24 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-2.51.61.61.48834941.55319446CS
4-0.03-1.886792452831.591.841.371973341.53370755CS
120.0641.51.841.1651996671.46484411CS
260.2418.18181818181.322.111.1652336841.58265616CS
52-3.09-66.45161290324.654.71.142539332.03898627CS
156-1.56-503.126.150.77625430493.40902433CS
260-1.6-50.63291139243.169.70.77625820883.91875209CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.34
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.95
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.69
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.49
(0.00%)
0
AACGATA Creativity Global
$ 0.84
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.34
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.95
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.69
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.49
(0.00%)
0
AACGATA Creativity Global
$ 0.84
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.34
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.95
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.69
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.49
(0.00%)
0
AACGATA Creativity Global
$ 0.84
(0.00%)
0

IFRX Discussion

View Posts
glenn1919 glenn1919 1 week ago
IFRX..................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
ralfito ralfito 2 weeks ago
What is up with IFRX? Seems to be teetering. Numbers look good, except for Forward EPS.
👍️0
glenn1919 glenn1919 4 weeks ago
IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
IFRX under $2
👍️0
Monksdream Monksdream 3 months ago
IFRX under $2
👍️0
glenn1919 glenn1919 3 months ago
IFRX................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 months ago
IFRX under $2
👍️0
Monksdream Monksdream 7 months ago
IFRX new 52 week low
👍️0
TheFinalCD TheFinalCD 7 months ago
https://finviz.com/quote.ashx?t=IFRX&ty=c&ta=1&p=d

does have a REGISTERED SHELF OFFERING

https://dilutiontracker.com/app/search/IFRX?a=dbb88c

Apr-05-23 Upgrade Guggenheim Neutral ? Buy $8
👍️0
enthalpy enthalpy 11 months ago
True waiting on that skin cancer p2 data release or EUA sales update.
👍️0
peterus peterus 11 months ago
going the wronge way
👍️0
peterus peterus 12 months ago
yup $10+ coming
👍️0
enthalpy enthalpy 12 months ago
I added more and its a decent position. I think we have a shot at 10 to 15 short term. Friday looked promising. Hopefully we get a second wave to start in 2 weeks.
👍️0
peterus peterus 1 year ago
you still in ????
im still holding 4s
👍️0
Gator44 Gator44 1 year ago
Closing of offering, here comes first stop $6.25
👍️0
frans frans 1 year ago
IFRX should go slowly 5$ +
👍️0
frans frans 1 year ago
IFRX 4.2 now slowly on the move
👍️0
frans frans 1 year ago
in here at 4.10
👍️0
the_stockoracle the_stockoracle 1 year ago
Still in downtrend and they will keep diluting
👍️0
enthalpy enthalpy 1 year ago
I bought more 4.04
👍️0
Gator44 Gator44 1 year ago
Couple of pennies are cloce enough
👍️0
the_stockoracle the_stockoracle 1 year ago
Learn your charts lol $3.93 is the gap fill
👍️0
Gator44 Gator44 1 year ago
Gap filled boys and girls...
Big boy buying today !!!
👍️0
peterus peterus 1 year ago
dont think we will see 3.50s
but it could happen with this market
👍️0
enthalpy enthalpy 1 year ago
Whats your thoughts on it hitting 3.50?
👍️0
the_stockoracle the_stockoracle 1 year ago
When it hits $3.93 tomorrow is where I’ll be buying my first order
👍️0
enthalpy enthalpy 1 year ago
Tomorrow we probably hit 3.75ish and that's close enough to the 62% fibonacci pullback. If it hits 3.75 rsi will be around mid 50s give or take which is good.
👍️0
enthalpy enthalpy 1 year ago
Probably right. I loaded some at 4.20 with rsi at 61 but i think 3.75 is the target. Glta.
👍️0
peterus peterus 1 year ago
beter on side line and buy bottom
👍️0
peterus peterus 1 year ago
it wil but not today
👍️0
the_stockoracle the_stockoracle 1 year ago
I thought you said going to $10 lol now you’re on the sideline this going to test the gaps fill $3.93
👍️0
peterus peterus 1 year ago
im still on side line
👍️0
the_stockoracle the_stockoracle 1 year ago
I disagree I’m going to be buying at $3.93 that’s the gap fill
👍️0
peterus peterus 1 year ago
4.40s 4.50s could be stronge support
👍️0
peterus peterus 1 year ago
agree
👍️0
the_stockoracle the_stockoracle 1 year ago
Ok today we will see $4 first step
👍️0
peterus peterus 1 year ago
lol will never see $2 maybe in your dreams lol
👍️0
the_stockoracle the_stockoracle 1 year ago
Lol ?? you’re delusional major diluting down to $2
👍️0
enthalpy enthalpy 1 year ago
I will be loading on the 10 million share offering. Looking for $3.50ish.
👍️0
RobP33 RobP33 1 year ago
New highs by EOW???
👍️0
enthalpy enthalpy 1 year ago
Only had 2 minutes missed the 4.60 buy.
👍️0
enthalpy enthalpy 1 year ago
We will see i have 1/3 of position bet at $5.00 but im playing this by the book.
👍️0
peterus peterus 1 year ago
yup i think you could be right
👍️0
enthalpy enthalpy 1 year ago
Fibonacci 38% pull back is $5.00 and 62% pull back is around $4.00. 78% is even further. Either one works. I flipped once for a big win but i think the second wave over several weeks will take this over $12.00.
👍️0
peterus peterus 1 year ago
fliped out
side line ... waiting
👍️0
enthalpy enthalpy 1 year ago
Waiting for $4.00. Enjoy the ride down.
👍️0
enthalpy enthalpy 1 year ago
Picked up 1/4 at 5.00. Waiting for rest around low 4.00ish.
👍️0
the_stockoracle the_stockoracle 1 year ago
Guys man why didn’t you take your profits when it jumped up huge mm’s are going to bring this back down to probably $3 to make back their money ?? if this was a pandemic full blown this would of hit $15 range but it isn’t revenues are way too small especially with all those others Covid therapies
👍️0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=ifrx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/ifrx/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/ifrx/opinion

below $4
👍️ 1
dinogreeves dinogreeves 1 year ago
IFRX should see minimum 10-11 this week. 2-3 months we could be sitting at 20-25 dollars or 1.5 billion dollar market cap.
👍️0

Your Recent History

NASDAQ
IFRX
InflaRx NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved